CD43 antibody (SPRD)
Quick Overview for CD43 antibody (SPRD) (ABIN135776)
Target
See all CD43 (SPN) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Brand
- Spectral Red ™
-
Specificity
- Human CD43, Mr 95-135 kDa
-
Characteristics
- Mouse Anti-Human CD43-SPRD
-
Immunogen
- KG-1 cells
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
- Applications: FC - Quality tested , IHC-FS - Reported in literature , IHC-PS - Reported in literature , ICC - Reported in literature , IP - Reported in literature , WB - Reported in literature , Adhesion - Reported in literature
- Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC, BIOT, PE, APC, and SPRD conjugates 10 L/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 100 tests in 1.0 mL of PBS/Sodium azide and a stabilizing agent
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
-
Do not freeze!
Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed. -
Storage
- 4 °C
-
Storage Comment
- Store at 2-8°C
-
-
- CD43 (SPN) (Sialophorin (SPN))
-
Alternative Name
- CD43
-
Background
- CD43, a member of the sialomucin family of cell surface receptors, is a 95-135 kDa type I transmembrane glycoprotein whose variability in molecular weight is dependent upon the nature of the extracellular O-glycans. It is the major sialoglycoprotein on thymocytes, T cells and neutrophils. It is also present on activated B cells, plasma cells, NK cells, granulocytes, monocytes, macrophages, platelets and bone marrow hematopoietic stem cells. CD43, which binds to ICAM-1 (CD54), appears to function as an anti-adhesion molecule, inhibiting T cell interactions, including T cell killing, and by increasing the threshold for T cell activation.
-
Pathways
- Regulation of Leukocyte Mediated Immunity
Target
-